NCT00124280View on ClinicalTrials.gov

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2007

Conditions
Non-small-cell Lung Carcinoma
Interventions
DRUG

RAD001

Trial Locations (2)

77030

MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology, Houston

89135

Nevada Cancer Institute, Las Vegas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY